Participation to the IABS “Innovations and Advances in Breast Surgery” Conference
We participate to the 3rd "Innovations and advances in Breast Surgery" (IABS) Conference at the University of Wolverhampton Science Park in…
Histolog® Scanner at the 2019 GRSSGO autumn days
SamanTree Medical is pleased to announce that the Histolog® Scanner will be showcased to the gynecological community during the 2019 autumn…
Histolog® Scanner at the 4th Joint Annual Meeting of the Swiss, Austrian Societies of Pathology
SamanTree Medical is pleased to announce that the Histolog® Scanner will be showcased to the pathologists community during the 4th Joint…
Histolog® Scanner presented at the ESSO39 congress
SamanTree Medical is pleased to announce that the Histolog® Scanner will be showcased to the oncology surgeon community during the 2019…
Histolog® Scanner at the AFIB 2019 congress
SamanTree Medical is pleased to announce that the Histolog® Scanner will be showcased to the biomedical engineers community during the 24th…
Participation to the Convergence in Oncology Summit
Mr Bastien Rachet, CEO of SamanTree Medical, will participate as speaker during the 2019 Convergence in Oncology Summit ! The Summit will…
Ambitious study started at Gustave Roussy
The Histolog Scanner is used on several hundreds of breast cancer surgical specimens involving breast surgeons and pathologists. This…
Promising results on breast biopsies published
"The Histolog Scanner offers great potential for immediate margin analysis of specimen in breast conserving therapy." A recently published…
SamanTree Medical raises CHF 9.5 million to assess the margins in cancer surgery
Following the promising clinical results achieved with its CE mark device, SamanTree Medical has recently closed a CHF 9.5 Million Series A…
CE Mark for Histolog™ Scanner new version
Latest version of the Histolog™ Scanner obtained the CE Mark for compliance with European Directives. The product has been upgraded to suit…